UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000050805
Receipt number R000057853
Scientific Title Influence of protein ingestion on dynamics in amino acids during hemodialysis
Date of disclosure of the study information 2023/06/01
Last modified on 2024/03/11 08:16:10

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Influence of protein ingestion on dynamics in amino acids during hemodialysis

Acronym

Influence of protein ingestion on dynamics in amino acids during hemodialysis

Scientific Title

Influence of protein ingestion on dynamics in amino acids during hemodialysis

Scientific Title:Acronym

Influence of protein ingestion on dynamics in amino acids during hemodialysis

Region

Japan


Condition

Condition

Hemodialysis

Classification by specialty

Nephrology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the influence of protein ingestion on dynamics in amino acids during hemodialysis

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Change in plasma amino acids concentration by ingestion of protein during hemodialysis

Key secondary outcomes

Change in spent dialysate amino acids blood concentration by ingestion of protein during hemodialysis


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

3

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Ingestion of protein during hemodialysis

Interventions/Control_2

Ingestion of another protein during hemodialysis

Interventions/Control_3

Usual care

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

60 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Patients on hemodialysis therapy for at least 3-month
2. Patients aged 60 and older
3. Patients who signed an informed consent

Key exclusion criteria

1. Patients with excessive weight gain between dialysis sessions
2. Patients who have a risk of severe dialysis-related complication
3. Patients who have hemodynamic instabilities
4. Patients with cognitive impairment
5. Patients who are identified as unsuitable for participation in the trial by an attending physician

Target sample size

10


Research contact person

Name of lead principal investigator

1st name Ryota
Middle name
Last name Matsuzawa

Organization

Hyogo Medical University

Division name

Graduate School of Health Science

Zip code

650-8530

Address

1-3-6 Minatojima, Chuo Ward, Kobe, Hyogo

TEL

078-304-3181

Email

ri-matsuzawa@hyo-med.ac.jp


Public contact

Name of contact person

1st name Ryota
Middle name
Last name Matsuzawa

Organization

Hyogo Medical University

Division name

Graduate School of Health Science

Zip code

650-8530

Address

1-3-6 Minatojima, Chuo Ward, Kobe, Hyogo

TEL

078-304-3181

Homepage URL


Email

ri-matsuzawa@hyo-med.ac.jp


Sponsor or person

Institute

Hyogo Medical University

Institute

Department

Personal name

Ryota Matsuzawa


Funding Source

Organization

Hyogo Medical University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor

Nissui Corporation

Name of secondary funder(s)

Nissui Corporation


IRB Contact (For public release)

Organization

The Ethics Review Board of Hyogo Medical University

Address

1-1 Mukogawa-cho, Nishinomiya, Hyogo

Tel

0798-45-6066

Email

rinri@hyo-med.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 06 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2023 Year 04 Month 01 Day

Date of IRB

2023 Year 11 Month 09 Day

Anticipated trial start date

2023 Year 12 Month 06 Day

Last follow-up date

2024 Year 06 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2023 Year 04 Month 10 Day

Last modified on

2024 Year 03 Month 11 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000057853


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name